Global Hospital Acquired Disease Testing Market by Infection Type, Diagnostic Tests, Growth Trends and Forecast to 2020, New Findings by iHealthcareAnalyst, Inc.
Summary
Rapid adoption of advanced molecular diagnostics methods, well defined regulatory framework and observation guidelines are the major factors driving the North America hospital acquired disease testing market.Major players operating in the global hospital acquired disease testing market and included in this report are Diatherix Laboratories Inc., Gen-Probe Inc., Qiagen GmbH, L Hoffman La Roche, Cepheid, Inc., Life Technologies Corporation, Meridian Biosciences, Cantel Medical Corporation, Nordion, Inc. and others.In addition to multi-client studies, we offer creative consulting services and conduct proprietary single-client assignments targeted at client’s specific business objectives, information needs, time frame and budget.Rapid adoption of advanced molecular diagnostics methods, well defined regulatory framework and observation guidelines are the major factors driving the North America hospital acquired disease testing market.The global hospital acquired disease testing market report estimates the market size (Revenue USD million - 2013 to 2020) for market segmentation based on disease test (blood stream associated infection, MRSA infection, Hospital-acquired pneumonia, surgical associated infection, UTI, Gastroenteritis, puerperal fever, etc.Please contact us to receive a proposal for a proprietary single-client study.Contact UsiHealthcareAnalyst, Inc.2109, Mckelvey Hill DriveMaryland Heights, MO 63043United StatesEmail: sales@ihealthcareanalyst.comWebsite: https://www.ihealthcareanalyst.com Contact Information iHealthcareAnalyst, Inc. Ana Aitawa (314) 500-7508 https://www.ihealthcareanalyst.com/ Click here to view the list of recent Press Releases from iHealthcareAnalyst, Inc. Promote Your Business Press Release Pricing Email this page to a friend